Mercer Global Advisors’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Sell |
225,234
-8,387
| -4% | -$130K | 0.01% | 658 |
|
|
2025
Q1 | $3.47M | Buy |
233,621
+59,266
| +34% | +$881K | 0.01% | 649 |
|
|
2024
Q4 | $2.31M | Sell |
174,355
-4,915
| -3% | -$65.1K | 0.01% | 775 |
|
|
2024
Q3 | $2.56M | Buy |
179,270
+9,214
| +5% | +$132K | 0.01% | 694 |
|
|
2024
Q2 | $2.2M | Sell |
170,056
-39,782
| -19% | -$515K | 0.01% | 697 |
|
|
2024
Q1 | $2.92M | Sell |
209,838
-2,933
| -1% | -$40.7K | 0.01% | 616 |
|
|
2023
Q4 | $3.04M | Sell |
212,771
-46,439
| -18% | -$663K | 0.01% | 607 |
|
|
2023
Q3 | $4.01M | Buy |
259,210
+90,669
| +54% | +$1.4M | 0.02% | 493 |
|
|
2023
Q2 | $2.65M | Buy |
168,541
+23,026
| +16% | +$362K | 0.01% | 645 |
|
|
2023
Q1 | $2.4M | Buy |
145,515
+13,749
| +10% | +$227K | 0.01% | 635 |
|
|
2022
Q4 | $2.06M | Buy |
131,766
+12,356
| +10% | +$193K | 0.01% | 680 |
|
|
2022
Q3 | $1.55M | Buy |
119,410
+2,109
| +2% | +$27.4K | 0.01% | 703 |
|
|
2022
Q2 | $1.65M | Buy |
117,301
+5,851
| +5% | +$82.2K | 0.01% | 664 |
|
|
2022
Q1 | $1.6M | Buy |
111,450
+29,570
| +36% | +$423K | 0.01% | 715 |
|
|
2021
Q4 | $1.12M | Sell |
81,880
-7,453
| -8% | -$102K | 0.01% | 835 |
|
|
2021
Q3 | $1.46M | Buy |
89,333
+9,703
| +12% | +$159K | 0.01% | 729 |
|
|
2021
Q2 | $1.34M | Sell |
79,630
-6,478
| -8% | -$109K | 0.01% | 719 |
|
|
2021
Q1 | $1.57M | Sell |
86,108
-1,366
| -2% | -$24.9K | 0.01% | 619 |
|
|
2020
Q4 | $1.59M | Sell |
87,474
-2,839
| -3% | -$51.7K | 0.02% | 479 |
|
|
2020
Q3 | $1.61M | Buy |
90,313
+3,375
| +4% | +$60.2K | 0.02% | 438 |
|
|
2020
Q2 | $1.56M | Buy |
86,938
+31,029
| +55% | +$556K | 0.03% | 375 |
|
|
2020
Q1 | $849K | Buy |
55,909
+20,004
| +56% | +$304K | 0.02% | 523 |
|
|
2019
Q4 | $708K | Sell |
35,905
-5,149
| -13% | -$102K | 0.01% | 613 |
|
|
2019
Q3 | $706K | Buy |
41,054
+5,882
| +17% | +$101K | 0.02% | 582 |
|
|
2019
Q2 | $623K | Sell |
35,172
-919
| -3% | -$16.3K | 0.02% | 608 |
|
|
2019
Q1 | $735K | Buy |
+36,091
| New | +$735K | 0.03% | 504 |
|